SOSeija Oikarinen

Seija Oikarinen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seija Oikarinen has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Green Leafy Vegetables in Cancer Prevention

    by Marja Mutanen, Mikael Niku, Seija Oikarinen


  • Genetic mapping of Mom5 , a novel modifier of Apc Min -induced intestinal tumorigenesis

    by Seija I. Oikarinen, Alicia G. Cleveland, Karlene M. Cork, Kimberly K. Bynoté, Joseph J. Rafter, Jan-Åke Gustafsson, Marja Mutanen, Karen A. Gould

    The initial purpose of this study was to assess the role of estrogen receptor β (ERβ) in intestinal tumorigenesis by examining the effects of an ERβ knockout (ERβ−/−) on ApcMin mice. In order to accomplish this goal on a uniform genetic background, we were required to backcross the ERβ knockout from the 129P2 genetic background to the B6 genetic background for 10 generations. Midway through this process, we performed a test cross in which mice from the N5 backcross generation of the ERβ knockout strain were intercrossed with ApcMin/+ mice to obtain ApcMin/+ ERβ+/+, ApcMin/+ ERβ+/− and ApcMin/+ ERβ−/− mice. Intestinal tumorigenesis in the N5F2 mice was evaluated at 14 weeks of age. The analysis of the impact of ERβ in the N5 cross was complicated by segregating 129P2-derived alleles that affected tumor number and were unlinked to ERβ. Genetic linkage analysis of this cross permitted the localization of a single genetic modifier of tumor number in ApcMin/+ mice. This locus, Modifier of Min 5 (Mom5), maps to proximal mouse chromosome 5; the 129P2 allele of this locus is associated with a 50% reduction in mean intestinal tumor number. Through in silico analysis and confirmatory sequencing, we have identified the Rad50-interacting protein-1 gene as a strong candidate for Mom5.


  • Open Access

    Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc Min/+ mice

    by Alicia G. Cleveland, Seija I. Oikarinen, Kimberly K. Bynoté, Maija Marttinen, Joseph J. Rafter, Jan-Åke Gustafsson, Shyamal K. Roy, Henry C. Pitot, Kenneth S. Korach, Dennis B. Lubahn, et al.

    Estrogen receptors (ERs) [ ER α ( Esr1 ) and ER β ( Esr2 )] are expressed in the human colon, but during the multistep process of colorectal carcinogenesis, expression of both ER α and ER β is lost, suggesting that loss of ER function might promote colorectal carcinogenesis. Through crosses between an ER α knockout and Apc Min mouse strains, we demonstrate that ER α deficiency is associated with a significant increase in intestinal tumor multiplicity, size and burden in Apc Min/+ mice. Within the normal intestinal epithelium of Apc Min/+ mice, ER α deficiency is associated with an accumulation of nuclear β-catenin, an indicator of activation of the Wnt–β-catenin-signaling pathway, which is known to play a critical role in intestinal cancers. Consistent with the hypothesis that ER α deficiency is associated with activation of Wnt–β-catenin signaling, ER α deficiency in the intestinal epithelium of Apc Min/+ mice also correlated with increased expression of Wnt–β-catenin target genes. Through crosses between an ER β knockout and Apc Min mouse strains, we observed some evidence that ER β deficiency is associated with an increased incidence of colon tumors in Apc Min/+ mice. This effect of ER β deficiency does not involve modulation of Wnt–β-catenin signaling. Our studies suggest that ER α and ER β signaling modulate colorectal carcinogenesis, and ER α does so, at least in part, by regulating the activity of the Wnt–β-catenin pathway.


    • 1 January 2008
      • p. 123-5

    Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse.

    by Marja Mutanen, Anne-Maria Pajari, Essi Päivärinta, Marjo Misikangas, Johanna Rajakangas, Maija Marttinen, Seija Oikarinen

    Berries contain a number of compounds that are proposed to have anticarcinogenic properties. We wanted to see if pure ellagic acid, natural ellagitannins and three wild berries have any effect on the adenoma formation in Apc- mutated Min/+ mice. Min/+ mice were fed high-fat AIN93-G diets containing 10% (w/w) freeze-dried bilberry (Vaccinium myrtillus), lingonberry (Vaccinium vitis-idaea), cloudberry (Rubus chamaemorus), cloudberry seeds or cloudberry pulp or pure ellagic acid at 1564 mg/kg for 10 weeks. beta-Catenin and cyclin D1 protein levels in the adenomas and in the normal-appearing mucosa were determined by Western blotting and immunohistochemistry. Early changes in gene expression in the normal-appearing mucosa were analyzed by Affymetrix microarrays. Three wild berries significantly reduced tumour number (15-30%, p < 0.05), and cloudberry and lingonberry also reduced tumour size by over 60% (p < 0.01). Cloudberry resulted in decreased levels of nuclear beta-catenin and cyclin D1 and lingonberry in the level of cyclin D1 in the large adenomas (p < 0.05). Affymetrix microarrays revealed changes in genes implicated in colon carcinogenesis, including the decreased expression of the adenosine deaminase, ecto-5f-nucleotidase and PGE2 receptor subtype EP4. Ellagic acid had no effect on the number or size of adenomas in the distal or total small intestine but it increased adenoma size in the duodenum when compared with the control diet (p < 0.05). Neither cloudberry seed nor pulp had any effect on the adenoma formation. Berries seem to have great potential as a source of chemopreventive components.


  • The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation

    by Anne-Maria Pajari, Annika I. Smeds, Seija I. Oikarinen, Patrik C. Eklund, Rainer E. Sjöholm, Marja Mutanen


  • Open Access

    Effects of a flaxseed mixture and plant oils rich in α-linolenic acid on the adenoma formation in multiple intestinal neoplasia (Min) mice

    by Seija I. Oikarinen, Anne-Maria Pajari, Irma Salminen, Satu-Maarit Heinonen, Herman Adlercreutz, Marja Mutanen

    Flaxseed is a dietary source of possible chemopreventive compounds such as lignans and α-linolenic acid (ALA). To study the effects of a flaxseed mixture on adenoma formation in multiple intestinal neoplasia mice, the mice were fed a diet containing 2·7 % flaxseed, 4·5 % fibre and 3·7 % ALA. To elucidate the effect of oils of the mixture we also composed a diet without flaxseed but with the same oil composition. The median number of adenomas in the small intestine was fifty-four for the control group, and thirty-seven (P=0·023) and forty-two (P=0·095) for flaxseed and oil groups, respectively. Compared with controls (1·2 mm), the adenoma size was smaller in the flaxseed (0·9 mm; P=0·002) and oil (1·0 mm; P=0·012) groups. Both diets changed the proportions of n-3 and n-6 fatty acids in the colonic mucosa. Membrane β-catenin and protein kinase C (PKC)-ζ levels were reduced in the adenoma v. mucosa (Pr −0·460, P=0·008, n 32). Only the flaxseed diet increased lignan levels in the caecum (P=0·002) and in plasma (P=0·002) but they were not associated with tumour formation. The results suggest that the preventive effect of flaxseed on colon carcinogenesis may be due to the oil part of flaxseed, and the loss of β-catenin and PKC-ζ from the membranes of the mucosal tissue may play a permissive role in intestinal tumour development.


  • Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model

    by A.-M. Aura, S. Oikarinen, M. Mutanen, S.-M. Heinonen, H. C. T. Adlercreutz, H. Virtanen, K. S. Poutanen

    In vitro fermentation models have been used widely for studies of shortchain fatty acid (SCFA) formation from carbohydrates, whereas the suitability of these methods for enterolactone (ENL) formation has received less attention. The aim was to study the suitability of an in vitro fermentation model for prediction of bioconversion of lignans to ENL, to compare the approach with that of an in vivo rat model and to study the SCFA formation in both models. Predigested samples of rye bran (R), flaxseed meal (F) alone, or in combination with rye bran (R&F) and a faecal control were incubated in an in vitro fermentation model using human faecal microbiota. In the in vivo experiment rats consumed a non–fibre control diet (C) or diets supplemented either with rye bran (R), flaxseed meal (F) alone, or with their combination (R&F) for four weeks. Enterodiol (END), ENL and SCFA concentrations were measured from in vitro faecal fermentation samples and from the intestinal contents of rats. Plasma ENL concentrations from rats were also measured. The highest ENL production was found in vitro with the F supplement (areas under curve: 740 ± 4, 7500 ± 400, 2600 ± 500 and 1520 ± 70 nmol · h for the R, F, R&F supplements and faecal control, respectively). In vivo, the concentration of ENL in caecal digesta from flaxseed meal was significantly (P < 0.05) enhanced by the presence of rye bran (medians 261, 407 and 24 nmol/g in the F, R&F and C groups, respectively). No correlation was found between the models regarding ENL production, possibly due to different responses to the presence of rye bran matrix, differences in microbiota or application of a batch in the in vitro fermentation model. Rye bran supplementation enhanced butyrate production both in vitro and in vivo. In vitro fermentation and the in vivo rat models responded differently to the presence of rye bran and no correlation with regard to the ENL formation from flaxseed lignans was observed.


  • No effect on adenoma formation in Min mice after moderate amount of flaxseed

    by Seija Oikarinen, S.-M. Heinonen, T. Nurmi, H. Adlercreutz, M. Mutanen


  • Open Access

    Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions

    by S. Oikarinen, S. Heinonen, S. Karppinen, J. Mättö, H. Adlercreutz, K. Poutanen, M. Mutanen

    The study was designed to evaluate whether two types of rye-bran fractions result in distinct bifidogenic effect or enterolactone production in multiple intestinal neoplasia (Min) mice and whether these parameters are associated with intestinal tumorigenesis in this animal model. The experimental diets were a non-fibre diet (control), a rye-bran diet, and diets containing either the soluble extract or the insoluble fraction prepared from rye bran. The main result on adenoma formation in these experiments was the observation that the soluble extract increased number (P=0·012) and size (P=0·008) of adenomas in the distal small intestine when compared with the non-fibre group. All rye-supplemented diets supported similarly the in vivo growth of Bifidobacterium (108–109 colony forming units/g) in Min mice, whereas the non-fibre diet lowered intestinal Bifidobacterium below the level of detection. The results show that water solubility does not affect the bifidogenicity of rye bran. Mean plasma enterolactone concentration was highest in the rye-bran group (30·0 nmol/l; P=0·002), which along with the soluble-extract group (16·2 nmol/l; P=0·024) differed significantly from the non-fibre diet group (7·5nmol/l). Thus, the mice fed with the rye bran were the best enterolactone producers. In conclusion, rye bran and rye fractions influence adenoma formation in Min mice to a varying degree but plasma enterolactone levels or the production of bifidogenic bacteria do not mediate the effect.